Maryland Department of Health - Forensic Review Board - Established
Summary
HB32 requires the Maryland Department of Health to establish forensic review boards at facilities that house people committed as not criminally responsible. These boards must review each committed person’s eligibility for release at least once a year, consider written statements from the person, and decide by majority vote whether to recommend discharge or conditional release to the court. The bill also allows the boards to make recommendations about rehabilitation and requires written findings, notice to the person and counsel, and inclusion of the board’s record in the person’s medical file.
The bill further creates a Community Forensic Aftercare Program within the Department to monitor people on conditional release. That program must meet with each monitored person and their mental health team at least every 90 days, may not make clinical treatment decisions, and must follow the treatment team’s recommendations. It also must handle violation reports, provide specified notice and information to the State’s Attorney and court, and respond to records requests within 48 hours unless disclosure is barred by law. The Department must adopt regulations to implement both the review board system and the aftercare program, and the act takes effect October 1, 2025.
Impact
HB32 amends the Criminal Procedure Article by adding a new section governing forensic review boards for committed persons found not criminally responsible and by clarifying notice and violation procedures for conditional release under § 3-121. It also adds a new subtitle to the Health-General Article establishing the Community Forensic Aftercare Program and defining its monitoring role. The bill affects the Maryland Department of Health, courts, State’s Attorneys, counsel for committed persons, treatment teams, and public defender or other advocates who may participate in board or aftercare meetings.
Sentiment
The bill appears to have broad support and little visible opposition. It passed the House unanimously 138-0 and the Senate unanimously 46-0, indicating strong bipartisan agreement on the need for a more structured review and aftercare process for committed persons. The absence of committee transcript discussion in the provided record also suggests no major public controversy surfaced in the available materials.
Contention
The main policy tensions in the bill are procedural rather than partisan. The legislation centralizes release review in health-care-based forensic boards, requires annual review, and limits who may attend board meetings, while also allowing a committed person to appoint an authorized agent or advocate. Another point of potential concern is the balance between treatment-team clinical authority and the new board/aftercare oversight structure, since the program may not make clinical decisions but must monitor compliance and relay violation information. Privacy and due-process issues may also arise from the bill’s record-sharing provisions and the exclusion of counsel from forensic review board meetings, although the unanimous votes suggest these issues were not contentious in the legislative process.